Harnessing neural circuits to restore immune homeostasis in disease
By targeting master regulator brain-body circuits that centrally control systemic inflammation, Nilo is pioneering a differentiated approach to immunomodulation with the potential to treat a wide spectrum of autoimmune and inflammatory diseases with large unmet need.
Backed by leading life sciences investors